JEFFREY PROVIZER: Open Payments
NPI 1316931405 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 57 payments from 18 companies in 2025. Trend: 2023 $600 · 2024 $656 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $228 |
| GlaxoSmithKline, LLC. | 11 | $150 |
| Lilly USA, LLC | 9 | $127 |
| Medtronic, Inc. | 1 | $116 |
| Ferring Pharmaceuticals Inc. | 2 | $70 |
| Amgen Inc. | 3 | $56 |
| PFIZER INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: Rybelsus, CARDIOBLATE GEMINI, Ozempic, TRELEGY ELLIPTA, MOUNJARO, REBYOTA, UBRELVY, AREXVY.
Industry payments across MI — which companies pay providers there.
